GSG Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
GSG Advisors's LLY Position: Q2 2026 in Review
GSG Advisors increased its Eli Lilly (LLY) stake by 7.8% in Q2 2026, buying an estimated $40.9K and bringing the position to 556 shares worth $667K. The position accounts for 0.15% of the portfolio, ranked #73.
GSG Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- GSG Advisors held 556 shares of Eli Lilly worth $667K as of Q2 2026.
- GSG Advisors bought 40 Eli Lilly shares in Q2 2026, an estimated $40.9K.
- Eli Lilly made up 0.15% of GSG Advisors's portfolio in Q2 2026, its #73 holding.
- GSG Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on GSG Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.